Skip to main content
PMC home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1984 Jul;77(7):542–549. doi: 10.1177/014107688407700704

Exogenous hormones in the aetiology of cancer in women.

M P Vessey
PMCID: PMC1439936  PMID: 6379176

Full text

PDF
543

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adam S. A., Sheaves J. K., Wright N. H., Mosser G., Harris R. W., Vessey M. P. A case-control study of the possible association between oral contraceptives and malignant melanoma. Br J Cancer. 1981 Jul;44(1):45–50. doi: 10.1038/bjc.1981.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bain C., Hennekens C. H., Speizer F. E., Rosner B., Willett W., Belanger C. Oral contraceptive use and malignant melanoma. J Natl Cancer Inst. 1982 Apr;68(4):537–539. [PubMed] [Google Scholar]
  3. Beral V., Colwell L. Randomised trial of high doses of stilboestrol and ethisterone in pregnancy: long-term follow-up of mothers. Br Med J. 1980 Oct 25;281(6248):1098–1101. doi: 10.1136/bmj.281.6248.1098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beral V., Ramcharan S., Faris R. Malignant melanoma and oral contraceptive use among women in California. Br J Cancer. 1977 Dec;36(6):804–809. doi: 10.1038/bjc.1977.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Boyce J. G., Lu T., Nelson J. H., Jr, Fruchter R. G. Oral contraceptives and cervical carcinoma. Am J Obstet Gynecol. 1977 Aug 1;128(7):761–766. doi: 10.1016/0002-9378(77)90717-7. [DOI] [PubMed] [Google Scholar]
  6. Brackbill Y., Berendes H. W. Dangers of diethylstilboestrol: Review of a 1953 paper. Lancet. 1978 Sep 2;2(8088):520–520. doi: 10.1016/s0140-6736(78)92237-7. [DOI] [PubMed] [Google Scholar]
  7. Brian D. D., Tilley B. C., Labarthe D. R., O'Fallon W. M., Noller K. L., Kurland L. T. Breast cancer in DES-exposed mothers: absence of association. Mayo Clin Proc. 1980 Feb;55(2):89–93. [PubMed] [Google Scholar]
  8. Brinton L. A., Hoover R. N., Szklo M., Fraumeni J. F., Jr Menopausal estrogen use and risk of breast cancer. Cancer. 1981 May 15;47(10):2517–2522. doi: 10.1002/1097-0142(19810515)47:10<2517::aid-cncr2820471035>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  9. Casagrande J. T., Louie E. W., Pike M. C., Roy S., Ross R. K., Henderson B. E. "Incessant ovulation" and ovarian cancer. Lancet. 1979 Jul 28;2(8135):170–173. doi: 10.1016/s0140-6736(79)91435-1. [DOI] [PubMed] [Google Scholar]
  10. Cramer D. W., Hutchison G. B., Welch W. R., Scully R. E., Knapp R. C. Factors affecting the association of oral contraceptives and ovarian cancer. N Engl J Med. 1982 Oct 21;307(17):1047–1051. doi: 10.1056/NEJM198210213071703. [DOI] [PubMed] [Google Scholar]
  11. DIECKMANN W. J., DAVIS M. E., RYNKIEWICZ L. M., POTTINGER R. E. Does the administration of diethylstilbestrol during pregnancy have therapeutic value? Am J Obstet Gynecol. 1953 Nov;66(5):1062–1081. doi: 10.1016/s0002-9378(16)38617-3. [DOI] [PubMed] [Google Scholar]
  12. Davis J. A., Wadehra V., McIntosh A. S., Monaghan J. M. A case of clear cell adenocarcinoma of the vagina in pregnancy. Br J Obstet Gynaecol. 1981 Mar;88(3):322–326. doi: 10.1111/j.1471-0528.1981.tb00989.x. [DOI] [PubMed] [Google Scholar]
  13. Edmondson H. A., Henderson B., Benton B. Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med. 1976 Feb 26;294(9):470–472. doi: 10.1056/NEJM197602262940904. [DOI] [PubMed] [Google Scholar]
  14. Franceschi S., La Vecchia C., Helmrich S. P., Mangioni C., Tognoni G. Risk factors for epithelial ovarian cancer in Italy. Am J Epidemiol. 1982 May;115(5):714–719. doi: 10.1093/oxfordjournals.aje.a113353. [DOI] [PubMed] [Google Scholar]
  15. Gambrell R. D., Jr, Maier R. C., Sanders B. I. Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users. Obstet Gynecol. 1983 Oct;62(4):435–443. [PubMed] [Google Scholar]
  16. Gambrell R. D., Jr, Massey F. M., Castaneda T. A., Ugenas A. J., Ricci C. A. Reduced incidence of endometrial cancer among postmenopausal women treated with progestogens. J Am Geriatr Soc. 1979 Sep;27(9):389–394. doi: 10.1111/j.1532-5415.1979.tb01673.x. [DOI] [PubMed] [Google Scholar]
  17. Harris R. W., Brinton L. A., Cowdell R. H., Skegg D. C., Smith P. G., Vessey M. P., Doll R. Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri. Br J Cancer. 1980 Sep;42(3):359–369. doi: 10.1038/bjc.1980.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Henderson B. E., Casagrande J. T., Pike M. C., Mack T., Rosario I., Duke A. The epidemiology of endometrial cancer in young women. Br J Cancer. 1983 Jun;47(6):749–756. doi: 10.1038/bjc.1983.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Henderson B. E., Preston-Martin S., Edmondson H. A., Peters R. L., Pike M. C. Hepatocellular carcinoma and oral contraceptives. Br J Cancer. 1983 Sep;48(3):437–440. doi: 10.1038/bjc.1983.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Henderson B. E., Ross R. K., Pike M. C., Casagrande J. T. Endogenous hormones as a major factor in human cancer. Cancer Res. 1982 Aug;42(8):3232–3239. [PubMed] [Google Scholar]
  21. Hildreth N. G., Kelsey J. L., LiVolsi V. A., Fischer D. B., Holford T. R., Mostow E. D., Schwartz P. E., White C. An epidemiologic study of epithelial carcinoma of the ovary. Am J Epidemiol. 1981 Sep;114(3):398–405. doi: 10.1093/oxfordjournals.aje.a113207. [DOI] [PubMed] [Google Scholar]
  22. Holly E. A., Weiss N. S., Liff J. M. Cutaneous melanoma in relation to exogenous hormones and reproductive factors. J Natl Cancer Inst. 1983 May;70(5):827–831. [PubMed] [Google Scholar]
  23. Hoover R., Glass A., Finkle W. D., Azevedo D., Milne K. Conjugated estrogens and breast cancer risk in women. J Natl Cancer Inst. 1981 Oct;67(4):815–820. [PubMed] [Google Scholar]
  24. Hoover R., Gray L. A., Sr, Cole P., MacMahon B. Menopausal estrogens and breast cancer. N Engl J Med. 1976 Aug 19;295(8):401–405. doi: 10.1056/NEJM197608192950801. [DOI] [PubMed] [Google Scholar]
  25. Hulka B. S., Chambless L. E., Deubner D. C., Wilkinson W. E. Breast cancer and estrogen replacement therapy. Am J Obstet Gynecol. 1982 Jul 15;143(6):638–644. doi: 10.1016/0002-9378(82)90108-9. [DOI] [PubMed] [Google Scholar]
  26. Hulka B. S., Chambless L. E., Kaufman D. G., Fowler W. C., Jr, Greenberg B. G. Protection against endometrial carcinoma by combination-product oral contraceptives. JAMA. 1982 Jan 22;247(4):475–477. [PubMed] [Google Scholar]
  27. Jick H., Walker A. M., Watkins R. N., D'Ewart D. C., Hunter J. R., Danford A., Madsen S., Dinan B. J., Rothman K. J. Replacement estrogens and breast cancer. Am J Epidemiol. 1980 Nov;112(5):586–594. doi: 10.1093/oxfordjournals.aje.a113031. [DOI] [PubMed] [Google Scholar]
  28. Kalache A., McPherson K., Barltrop K., Vessey M. P. Oral contraceptives and breast cancer. Br J Hosp Med. 1983 Oct;30(4):278–283. [PubMed] [Google Scholar]
  29. Kaufman D. W., Shapiro S., Slone D., Rosenberg L., Miettinen O. S., Stolley P. D., Knapp R. C., Leavitt T., Jr, Watring W. G., Rosenshein N. B. Decreased risk of endometrial cancer among oral-contraceptive users. N Engl J Med. 1980 Oct 30;303(18):1045–1047. doi: 10.1056/NEJM198010303031807. [DOI] [PubMed] [Google Scholar]
  30. Kelsey J. L., Fischer D. B., Holford T. R., LiVoisi V. A., Mostow E. D., Goldenberg I. S., White C. Exogenous estrogens and other factors in the epidemiology of breast cancer. J Natl Cancer Inst. 1981 Aug;67(2):327–333. [PubMed] [Google Scholar]
  31. Kelsey J. L., LiVolsi V. A., Holford T. R., Fischer D. B., Mostow E. D., Schwartz P. E., O'Connor T., White C. A case-control study of cancer of the endometrium. Am J Epidemiol. 1982 Aug;116(2):333–342. doi: 10.1093/oxfordjournals.aje.a113417. [DOI] [PubMed] [Google Scholar]
  32. Kinlen L. J., Badaracco M. A., Moffett J., Vessey M. P. A survey of the use of oestrogens during pregnancy in the United Kingdom and of the genito-urinary cancer mortality and incidence rates in young people in England and Wales. J Obstet Gynaecol Br Commonw. 1974 Nov;81(11):849–855. doi: 10.1111/j.1471-0528.1974.tb00395.x. [DOI] [PubMed] [Google Scholar]
  33. La Vecchia C., Franceschi S., Gallus G., Decarli A., Colombo E., Mangioni C., Tognoni G. Oestrogens and obesity as risk factors for endometrial cancer in Italy. Int J Epidemiol. 1982 Jun;11(2):120–126. doi: 10.1093/ije/11.2.120. [DOI] [PubMed] [Google Scholar]
  34. McPherson K., Neil A., Vessey M. P., Doll R. Oral contraceptives and breast cancer. Lancet. 1983 Dec 17;2(8364):1414–1415. doi: 10.1016/s0140-6736(83)90936-4. [DOI] [PubMed] [Google Scholar]
  35. Monaghan J. M., Sirisena L. A. Stilboestrol and vaginal clear-cell adenocarcinoma syndrome. Br Med J. 1978 Jun 17;1(6127):1588–1590. doi: 10.1136/bmj.1.6127.1588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Newhouse M. L., Pearson R. M., Fullerton J. M., Boesen E. A., Shannon H. S. A case control study of carcinoma of the ovary. Br J Prev Soc Med. 1977 Sep;31(3):148–153. doi: 10.1136/jech.31.3.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Noller K. L., Townsend D. E., Kaufman R. H., Barnes A. B., Robboy S. J., Fish C. R., Jefferies J. A., Bergstralh E. J., O'Brien P. C., McGorray S. P. Maturation of vaginal and cervical epithelium in women exposed in utero to diethylstilbestrol (DESAD Project). Am J Obstet Gynecol. 1983 Jun 1;146(3):279–285. doi: 10.1016/0002-9378(83)90749-4. [DOI] [PubMed] [Google Scholar]
  38. Peritz E., Ramcharan S., Frank J., Brown W. L., Huang S., Ray R. The incidence of cervical cancer and duration of oral contraceptive use. Am J Epidemiol. 1977 Dec;106(6):462–469. doi: 10.1093/oxfordjournals.aje.a112492. [DOI] [PubMed] [Google Scholar]
  39. Pike M. C., Henderson B. E., Casagrande J. T., Rosario I., Gray G. E. Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer. 1981 Jan;43(1):72–76. doi: 10.1038/bjc.1981.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Pike M. C., Henderson B. E., Krailo M. D., Duke A., Roy S. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet. 1983 Oct 22;2(8356):926–930. doi: 10.1016/s0140-6736(83)90450-6. [DOI] [PubMed] [Google Scholar]
  41. Rooks J. B., Ory H. W., Ishak K. G., Strauss L. T., Greenspan J. R., Hill A. P., Tyler C. W., Jr Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA. 1979 Aug 17;242(7):644–648. [PubMed] [Google Scholar]
  42. Rosenberg L., Shapiro S., Slone D., Kaufman D. W., Helmrich S. P., Miettinen O. S., Stolley P. D., Rosenshein N. B., Schottenfeld D., Engle R. L., Jr Epithelial ovarian cancer and combination oral contraceptives. JAMA. 1982 Jun 18;247(23):3210–3212. [PubMed] [Google Scholar]
  43. Ross R. K., Paganini-Hill A., Gerkins V. R., Mack T. M., Pfeffer R., Arthur M., Henderson B. E. A case-control study of menopausal estrogen therapy and breast cancer. JAMA. 1980 Apr 25;243(16):1635–1639. [PubMed] [Google Scholar]
  44. Sherman B., Wallace R., Bean J. Estrogen use and breast cancer. Interaction with body mass. Cancer. 1983 Apr 15;51(8):1527–1531. doi: 10.1002/1097-0142(19830415)51:8<1527::aid-cncr2820510828>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  45. Shy K. K., McTiernan A. M., Daling J. R., Weiss N. S. Oral contraceptive use and the occurrence of pituitary prolactinoma. JAMA. 1983 Apr 22;249(16):2204–2207. [PubMed] [Google Scholar]
  46. Stern E., Forsythe A. B., Youkeles L., Coffelt C. F. Steroid contraceptive use and cervical dysplasia: increased risk of progression. Science. 1977 Jun 24;196(4297):1460–1462. doi: 10.1126/science.867043. [DOI] [PubMed] [Google Scholar]
  47. Swan S. H., Brown W. L. Oral contraceptive use, sexual activity, and cervical carcinoma. Am J Obstet Gynecol. 1981 Jan;139(1):52–57. doi: 10.1016/0002-9378(81)90411-7. [DOI] [PubMed] [Google Scholar]
  48. Swan S. H., Petitti D. B. A review of problems of bias and confounding in epidemiologic studies of cervical neoplasia and oral contraceptive use. Am J Epidemiol. 1982 Jan;115(1):10–18. doi: 10.1093/oxfordjournals.aje.a113264. [DOI] [PubMed] [Google Scholar]
  49. Swyer G. I. Determination of progestational potency: a review. J R Soc Med. 1984 May;77(5):406–409. doi: 10.1177/014107688407700514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Thomas D. B. Non-contraceptive exogenous estrogens and risk of breast cancer: a review. Breast Cancer Res Treat. 1982;2(3):203–211. doi: 10.1007/BF01806932. [DOI] [PubMed] [Google Scholar]
  51. Thomas D. B., Persing J. P., Hutchinson W. B. Exogenous estrogens and other risk factors for breast cancer in women with benign breast diseases. J Natl Cancer Inst. 1982 Nov;69(5):1017–1025. [PubMed] [Google Scholar]
  52. Thomas D. B. Relationship of oral contraceptives to cervical carcinogenesis. Obstet Gynecol. 1972 Oct;40(4):508–518. [PubMed] [Google Scholar]
  53. Vessey M. P., Fairweather D. V., Norman-Smith B., Buckley J. A randomized double-blind controlled trial of the value of stilboestrol therapy in pregnancy: long-term follow-up of mothers and their offspring. Br J Obstet Gynaecol. 1983 Nov;90(11):1007–1017. doi: 10.1111/j.1471-0528.1983.tb06438.x. [DOI] [PubMed] [Google Scholar]
  54. Vessey M. P., Lawless M., McPherson K., Yeates D. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill. Lancet. 1983 Oct 22;2(8356):930–934. doi: 10.1016/s0140-6736(83)90451-8. [DOI] [PubMed] [Google Scholar]
  55. Vessey M. P., Lawless M., McPherson K., Yeates D. Oral contraceptives and cervical cancer. Lancet. 1983 Dec 10;2(8363):1358–1359. doi: 10.1016/s0140-6736(83)91108-x. [DOI] [PubMed] [Google Scholar]
  56. Vessey M. P., McPherson K., Yeates D., Doll R. Oral contraceptive use and abortion before first term pregnancy in relation to breast cancer risk. Br J Cancer. 1982 Mar;45(3):327–331. doi: 10.1038/bjc.1982.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Weiss N. S., Lyon J. L., Liff J. M., Vollmer W. M., Daling J. R. Incidence of ovarian cancer in relation to the use of oral contraceptives. Int J Cancer. 1981 Dec;28(6):669–671. doi: 10.1002/ijc.2910280602. [DOI] [PubMed] [Google Scholar]
  58. Weiss N. S., Sayvetz T. A. Incidence of endometrial cancer in relation to the use of oral contraceptives. N Engl J Med. 1980 Mar 6;302(10):551–554. doi: 10.1056/NEJM198003063021004. [DOI] [PubMed] [Google Scholar]
  59. Willett W. C., Bain C., Hennekens C. H., Rosner B., Speizer F. E. Oral contraceptives and risk of ovarian cancer. Cancer. 1981 Oct 1;48(7):1684–1687. doi: 10.1002/1097-0142(19811001)48:7<1684::aid-cncr2820480735>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  60. Worth A. J., Boyes D. A. A case control study into the possible effects of birth control pills on pre-clinical carcinoma of the cervix. J Obstet Gynaecol Br Commonw. 1972 Aug;79(8):673–679. doi: 10.1111/j.1471-0528.1972.tb12899.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES